Importance of home study visit capacity in dementia studies

详细信息    查看全文

• 作者：Paul K. Crane^a ; ^{pcrane@uw.edu" class="auth_mail" title="E-mail the corresponding author} ; Laura E. Gibbons^a ; Susan M. McCurry^b ; Wayne McCormick^a ; James D. Bowen^c ; Joshua Sonnen^d ; C. Dirk Keene^e ; Thomas Grabowski^f ; Thomas J. Montine^e ; Eric B. Larson^g
• 关键词：Home research study visits ; Research clinic study visits ; Missing data ; Bias ; Prospective studies ; Cohort studies ; Longitudinal studies ; Inference ; Dementia ; Neuropathology
• 刊名：Alzheimer's & Dementia
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：12
• 期：4
• 页码：419-426
• 全文大小：661 K

文摘

The importance of home research study visit capacity in Alzheimer's disease (AD) studies is unknown.

Methods

All evaluations are from the prospective Adult Changes in Thought study. Based on analyses of factors associated with volunteering for a new in-clinic initiative, we analyzed AD risk factors and the relevance of neuropathologic findings for dementia comparing all data including home visits, and in-clinic data only. We performed bootstrapping to determine whether differences were greater than expected by chance.

Results

Of the 1781 people enrolled during 1994–1996 with ≥1 follow-up, 1369 (77%) had in-clinic data, covering 61% of follow-up time. In-clinic data resulted in excluding 76% of incident dementia and AD cases. AD risk factors and the relevance of neuropathologic findings for dementia were both different with in-clinic data.

Discussion

Limiting data collection in AD studies to research clinics alone likely reduces power and also can lead to erroneous inferences.